Coller Capital Ltd. is a private equity firm based in London, United Kingdom, established in 1990. It specializes in secondary market investments, providing liquidity to investors looking to exit their private equity positions, which may include limited partner stakes in funds or portfolios of direct investments in private companies. The firm targets a diverse range of investment opportunities, focusing on sectors such as life sciences, telecommunications, real estate, and information technology. Coller Capital typically invests between $1 million and over $1 billion in transactions, often seeking to be the lead investor while holding minority stakes in medium-sized companies. With a global investment strategy, the firm concentrates on markets in Asia, Europe, the Middle East, and the United States, among others. Coller Capital aims for exits within four to six years, primarily through initial public offerings or trade sales.
Exterro, Inc. specializes in e-discovery and information governance software solutions tailored for legal and IT markets, as well as Fortune 500 corporations. The company's Fusion Platform serves as a comprehensive tool that integrates with existing enterprise technologies, fostering collaboration among legal, IT, records management, and compliance teams. Exterro's offerings include E-Discovery Data Mapping, Legal Hold for privacy compliance, E-Discovery Data Management for data collection and analysis, and E-Discovery Project Management for legal teams. Additionally, the company provides a Case Law Library, Data Source Discovery solutions, and cloud-based e-discovery software. Exterro also offers tools to monitor changes in HR data to mitigate associated risks. Founded in 2004 and headquartered in Beaverton, Oregon, Exterro has established itself as a leader in legal governance, risk management, and compliance, with operations across the United States and internationally.
Hoxton Farms, located in London, UK, specializes in producing real animal fat without the use of animals. The company employs a unique combination of cell biology and mathematical modeling to create cultivated fat, specifically designed as an ingredient for the meat alternatives industry. By utilizing a tissue culture system in bioreactors, Hoxton Farms offers purified animal fat that serves various sectors, including meat, bakery, confectionery, and cosmetics, thus providing a cruelty-free option for manufacturers seeking sustainable ingredients.
BOOK A TIGER is an integrated facility management platform that specializes in providing high-quality cleaning services to customers. It operates as an online booking platform, enabling users to easily schedule home cleaning services. In addition to cleaning, BOOK A TIGER offers a range of supplementary services through its network of connected partners, ensuring a comprehensive solution for various facility management needs. The platform focuses on delivering convenience and quality to its users, making it a go-to choice for those seeking reliable cleaning and facility management services.
uniQure N.V., a gene therapy company, engages in the development and commercialization of treatments for patients suffering from genetic and other diseases in the Netherlands. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington’s disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-180, an one-time intravenously-administered gene therapy candidate, which is in preclinical stage for the treatment of hemophilia A; and AMT-190, an IV-administered adeno-associated virus 5-based gene therapy for the treatment of Fabry disease. In addition, it engages in developing AMT-150, a gene therapy candidate for the treatment of Spinocerebellar Ataxia Type 3 disease. The company has collaboration and license agreements with Bristol Myers-Squibb Company; Gen-X; and Synpromics Limited. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Societe Innovatech du Grand Montreal
Acquisition in 2004
Societe Innovatech du Grand Montreal
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.